[A18-21] Patiromer (hyperkalaemia) - Benefit assessment according to §35a Social Code Book V
Last updated 02.07.2018
Project no.:
A18-21
Commission:
Commission awarded on 28.03.2018 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Heart and circulation
Indication:
Hyperkalaemia in adults
Result of dossier assessment:
Added benefit not proven due to lack of suitable study data
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A24-14 | Patiromer (hyperkalaemia in children and adolescents) – Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2018-09-20 A G-BA decision was published.